PAUL STRECK - 19 Dec 2022 Form 3 Insider Report for ALBIREO PHARMA, INC.

Role: Chief Medical Officer
Signature: /s/ Jason Duncan, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 19 Dec 2022
Net transactions value: $0
Form type: 3
Filing time: 21 Dec 2022, 15:05:26 UTC
Next filing: 27 Jan 2023
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney